Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin

Journal of Pineal Research

Volumn 25, Issue 2, 1998, Pages 94-100

  Montilla, Pedro López ^a   Vargas, José Fresno ^a   Túnez, Isaac Fiñana ^a   Muñoz, M Carmen ^a   De Agueda, ^a   Valdelvira, M Elías Díaz ^a   Cabrera, Emilio Sánchez ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Antioxidants; Diabetes; Melatonin; Oxidative stress

Indexed keywords

CHOLESTEROL; FREE RADICAL; GLUCOSE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDOLE; LIPID PEROXIDE; MELATONIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ERYTHROCYTE; FEMALE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OXIDATIVE STRESS; PINEAL BODY; PROTEIN GLYCOSYLATION; RAT; STREPTOZOCIN DIABETES;

EID: 0008236684     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1998.tb00545.x     Document Type: Article

References (36)

1. ABDEL-WAHAB, Y.H., F.P. O'HARTE, H. RATCLIFF, N.H. MCCLENAGHAN, C.R. BARNETT, P.R. FLATT (1996) Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45:1489-1496.
2. AUGUSTIN, A.J., W. BREIPOHL, T. BOKER, J. LUTZ, M. SPITZNAS (1993) Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 231:647-650.
3. BARLOW-WALDEN, L.R., R.J. REITER, M. ABE, M. PABLOS, A. MENÉNDES-PELAEZ, B. POEGGELER (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:497-502.
4. BAYNES, J.W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
5. BRZOZOWSKI, T., P.CR. KONTUREK, S.J. KONTUREK, R. PAJDO, W. BIELANSKI, I. BRZOZOWSKA, J. STACHURA, E.G. HABN (1997) The role of melatonin and L-tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia and aspirin. J. Pineal Res. 23:79-80.
6. CAMERON, N.B., M.A. COTTER (1993) Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabetic Med. 10:593-605.
7. CARNEIRO, R.C.G., R.J. REITER (1997) Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience 82:293-299.
8. CERIELLO, A., D. GIUGLIANO, A. QUATRARO, C. DONZELLA, G. DIPALO, P.J. LEFEBVRE (1991) Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 14:68-72.
9. CERIELLO, A., N. BORTOLOTTI, E. FALLETI, C. TABOGA, L. TONUTTI, A. CRESCENTINI, E. MOTZ, S. LIZZIO, A. RUSSO, E. BARTOLI (1997) Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20:194-197.
10. CERIELLO, A., N. BORTOLOTTI, M. PIRISI, A. CRESCENTINI, L. TONUTTI, E. MOTZ, A. Russo, R. GIACOMELLO, G. STEL, G. TABOGA (1997) Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 20:1589-1593.
11. COSTA, E.J.X., R.H. LÓPEZ, M.T. LAMY-FREUND (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19:123-123.
12. GIUGLIANO, D., A. CERIELLO, G. PAOLISSO (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267.
13. HAFFNER, S.M., A. AGIL, L. MYKKANEN, M.P. STERN, I. JIALAL (1995) Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabetes Care 18:646-653.
14. HUNT, J.V., R.T. DEAN, S.P. WOLFF (1988) Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem. J. 256:205-121.
15. HUNT, J.V., C. SMITH, S.P. WOLFF (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424.
16. HYSLOP, P.A., D.B. HINSHAW, W.A. JR. HALSEY (1988) Mechanism of oxidant-mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J. Biol. Chem. 263:1665-1675.
17. IANAS, O., R. OLNESCU, I. BADESCU (1991) Melatonin involvement in oxidative stress. Rom. J. Endocrinol. 29:147-153.
18. KELLY, M.R., G. LOO (1997) Melatonin inhibits oxidative modification of human low-density lipoprotein. J. Pineal Res. 22:203-209.
19. LI, Z.R., R.J. REITER, O. FUJIMORI, C.S. OH, Y.P. DUAN (1997) Cataractogenesis and lipid peroxidation preventive actions of melatonin. J. Pineal Res. 22:117-123.
20. LOWRY, O.H., N.J. ROSEBROUGH, A.C. FARR, R.J. RANDALL (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. MENDIOLA, J., J.R. WRIGHT, P.E. LACY (1987) Oxygen free radicals scavengers and immune destruction of murine allograft rejection and multiple low-dose streptozotocin-induced insulitis. Diabetes 38:379-385.
22. MONTILLA, P., J.L. MUÑOZ, M.C. MUÑOZ, J.A. MONTILLA, M. SALCEDO (1992) Lipoperóxidos en la diabetes por estreptozotocina en ratas: Efectos de la administración de insulina. Clin. Invest. Arteriosclerosis 4:149-152.
23. MUÑOZ, M.C., I. TÚNEZ, T. PORRAS, P. MONTILLA (1993) Curso evolutivo de la glucosa, fructosamina y lipoperóxidos plasmáticos en ratas diabéticas por estreptozotocina. Efecto de la vitamina E. Clin. Invest. Arteriosclerosis 5:114-117.
24. PIERREFICHE, G., G. TOPALL, G. COURBOIN, I. HENRIT, H. LABORIT (1993) Antioxidant activity of melatonin mice. Res. Commun. Chem. Pathol. Pharmacol. 80:211-223.
25. POZO, D., R.J. REITER, J.P. CALVO, J.M. GUERRERO (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 65:PL455-PL460.
26. PRINC, F.G., A.A. JUBNAT, A.G. MAXIT, C. CARDALDA, A. BATLLE (1997) Melatonin's antioxidant protection against δ-aminolevulinic acid induced oxidative damage in rat cerebellum. J. Pineal Res. 23:40-46.
27. REITER, R.J. (1995) Functional pleiotropy of the neurohormone melatonin: Antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 16:384-415.
28. REITER, R.J. (1996) Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals. Eur. J. Endocrinol. 134:412-420.
29. REITER, R.J., B. POEGGELER, D.X. TAN, L.D. CHEN, L.C. MANCHESTER, J.M. GUERRERO (1993) Antioxidant capacity of melatonin: Nobel action not requiring receptor. Neuroendocrinol. Lett. 15:103-116.
30. REITER, R.J., L. TANG, J.J. GARCIA, A. MUÑOZ-HOYOS (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:2255-2271.
31. SAMUELSSON, B., S.E. DAHLEN, J.A. LINDGREN, C.A. ROUZER, C.N. SERHAN (1987) Leukotrienes and lipoxins: Structures biosynthesis, and biological effects. Science 237:1171-1176.
32. SASAKI, J., G.L. COTTAM (1982) Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim. Biophys. Acta. 713:199-207.
33. TAN, D.X., L.D. CHEN, B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:57-60.
34. VAN KAMPEN, E.J., N.J. ZIJLSTRA (1961) Standardization of hemoglobinometry. II. The hemoglobinocyanide method. Clin. Chim. Acta 6:538-545.
35. WHARTON, A.R., M.E. MONTGOMERY, R.S. KENT (1985) Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells. J. Clin. Invest. 76:295-302.
36. WILHELM, S., H. SIES (1997) Antioxidant defense: vitamins E and C and carotenoids. Diabetes 46:S14-S18.